Search research articles
Contact Us
Filters
Showing results (931-940 of 1,038) with videos related to
Page
of 104
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment
Mark Roschewski, Manish R Patel, Patrick M Reagan, et al.
Oncotarget
|
April 17, 2017
The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia
Cecelia R Miller, Amy S Ruppert, Sydney Fobare, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2007
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma
Javier Bolaños-Meade, Elizabeth Garrett-Mayer, Leo Luznik, et al.
Haematologica
|
December 17, 2016
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study
Gilles Salles, Stephen J Schuster, Sven de Vos, et al.
Cancer Genetics
|
March 12, 2014
Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants
Cathy C Laurie, Cecelia A Laurie, Stephanie A Smoley, et al.
Annals of Neurology
|
September 13, 2013
TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency
Laura J Flinn, Marcus Keatinge, Sandrine Bretaud, et al.
Genomics
|
April 17, 2023
Genome-wide gene expression responses to experimental manipulation of Saccharomyces cerevisiae repressor activator protein 1 (Rap1) expression level
S Kalra, R Peyser, J Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 2026
Genome-wide association mapping and targeted loss of function studies identify <i>Shroom3</i> as a driver of hyperpolyploidy and ventricular dilation
Alexandra L Purdy, Amirala Bakhshian Nik, Anooj A Arkatkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2017
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
Umberto Vitolo, Marek Trněný, David Belada, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
April 2, 2025
The Current State of Care for Tuberous Sclerosis Complex in Canada
Robyn Whitney, Maryam Nabavi Nouri, Lauren Sham, et al.
Page
of 104
Search research articles
Search
Showing results (931-940 of 1,038) with videos related to
Sort By:
Page
of 104
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 26, 2023
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment
Mark Roschewski, Manish R Patel, Patrick M Reagan, et al.
Oncotarget
|
April 17, 2017
The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia
Cecelia R Miller, Amy S Ruppert, Sydney Fobare, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 25, 2007
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma
Javier Bolaños-Meade, Elizabeth Garrett-Mayer, Leo Luznik, et al.
Haematologica
|
December 17, 2016
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study
Gilles Salles, Stephen J Schuster, Sven de Vos, et al.
Cancer Genetics
|
March 12, 2014
Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants
Cathy C Laurie, Cecelia A Laurie, Stephanie A Smoley, et al.
Annals of Neurology
|
September 13, 2013
TigarB causes mitochondrial dysfunction and neuronal loss in PINK1 deficiency
Laura J Flinn, Marcus Keatinge, Sandrine Bretaud, et al.
Genomics
|
April 17, 2023
Genome-wide gene expression responses to experimental manipulation of Saccharomyces cerevisiae repressor activator protein 1 (Rap1) expression level
S Kalra, R Peyser, J Ho, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 26, 2026
Genome-wide association mapping and targeted loss of function studies identify <i>Shroom3</i> as a driver of hyperpolyploidy and ventricular dilation
Alexandra L Purdy, Amirala Bakhshian Nik, Anooj A Arkatkar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 2017
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
Umberto Vitolo, Marek Trněný, David Belada, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
April 2, 2025
The Current State of Care for Tuberous Sclerosis Complex in Canada
Robyn Whitney, Maryam Nabavi Nouri, Lauren Sham, et al.
Page
of 104